"Chemokine CXCL6" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CXC chemokine that has stimulatory and chemotactic activities towards NEUTROPHILS. It has specificity for CXCR1 RECEPTORS and CXCR2 RECEPTORS.
| Descriptor ID |
D054427
|
| MeSH Number(s) |
D12.644.276.374.200.120.300 D12.776.467.374.200.120.300 D23.125.300.120.300 D23.469.200.120.300 D23.529.374.200.120.300
|
| Concept/Terms |
Chemokine CXCL6- Chemokine CXCL6
- CXCL6, Chemokine
- Small Inducible Cytokine B6
- CXCL6 Chemokine
- Chemokine, CXCL6
- Granulocyte Chemotactic Protein-2
- Chemotactic Protein-2, Granulocyte
- Granulocyte Chemotactic Protein 2
- Chemokine (C-X-C Motif) Ligand 6
- Chemokine alpha 3
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL6".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL6".
This graph shows the total number of publications written about "Chemokine CXCL6" by people in this website by year, and whether "Chemokine CXCL6" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemokine CXCL6" by people in Profiles.
-
Stanniocalcin-1 inhibits thrombin-induced signaling and protects from bleomycin-induced lung injury. Sci Rep. 2015 Dec 07; 5:18117.
-
Elevated expression of CXC chemokines in pediatric osteosarcoma patients. Cancer. 2011 Jan 01; 117(1):207-17.
-
Chemokine CXCL16 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration. Am J Pathol. 2009 Dec; 175(6):2518-27.
-
A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response. Infect Immun. 2008 Mar; 76(3):978-85.